This effect is not listed in the UK Summary of Product Characteristics or Patient Information Leaflet as a recognised side effect
The list of FDA-approved indications for this class of medication has grown as of late (and currently includes type 2 diabetes, obesity, cardiovascular event risk reduction, obstructive sleep apnea, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease), and areas of interest for potential future indications are just as long and farreaching
She's a sports dietitian, diabetes specialist, and longtime endurance athlete
Fatty meals, particularly those with animal fats, are frequent culprits
[DOI] [PubMed] [Google Scholar] 19.Evolution of GLP1 Receptor Agonists for Diabetes Treatment
The combination may also help reduce appetite and cravings, further supporting weight management